Skip to main content
Enlyte Logo
  • Referrals
  • Pharmacy Locator
  • Find a Genex Provider
  • Find a Coventry Provider
  • Enlyte360
  • APD Solutions
  • Casualty Solutions
    • Solutions
      • Cost Containment Services
        • Medical Bill Review
          • Bill Audit
          • Electronic Payments
          • Negotiations
          • Regulatory Reporting
          • Specialty Bill Review
        • Injury & Liability
          • Bodily Injury Integrated Solutions
          • Demand Package Review
          • Injury Evaluation
          • Medical Records Summarization
      • Injury Management
        • Case Management
          • Field Case Management
          • Telephonic Case Management
          • Catastrophic Case Management/Crisis Response
          • Vocational Case Management
          • Ergonomics and Physical Demands
          • Alternative Transitional Duty
        • Medicare Set-Aside
        • Nurse Triage
        • Utilization Review
      • Network Management
        • Broad-Based Networks
        • Outcomes-Based Network
        • State-Certified Managed Care Plans
      • Pharmacy Benefit Management
        • Clinical Pharmacy Management
        • Pharmacy Intervention
      • Specialty Services
        • Diagnostics
        • Durable Medical Equipment
        • Home Health Care
        • Orthotics and Prosthetics
        • Physical Medicine
        • Translation
        • Transportation
        • Additional Services
  • Disability Solutions
    • Solutions
      • Manage Disability and Absence
        • Short-term and Long-term Disability
        • Absence Management for Payers
        • STD and ADAAA Services for Employers
      • Social Security and Disability
        • Carrier and Self Insured
        • Disabled Individuals
          • Social Security Team
          • Social Security Lookup
          • Social Security Training
        • Medicare Counseling Services
        • Ticket to Work
  • Tools
    • Solutions
      • Adjusters
        • Enlyte360
        • Locations
        • Make a Referral
        • Resource Hub
      • Clients
        • Enlyte Portal
        • Find a Provider
        • Client Specific Networks
        • Customer Reporting
        • ScriptAdvisor Resources
      • Providers
        • Apricus Provider Resources
        • Coventry Provider Resources
          • Provider Portal
      • Injured/Disabled Individuals
        • Pharmacy Locator
        • Social Security Lookup
        • My Account
  • Insights
    • CE Webinars
    • Events
    • Regulatory & Compliance
    • Trend Reports
    • More Expert Insights ›
  • About Enlyte
    • Values and Culture
    • Leadership
    • News
    • Careers
  • Home
  • Insights
  • Auto Casualty
  • Events
  • COVID-19: Effects on Auto Insurance Industry [Podcast]
Auto Casualty

COVID-19: Effects on Auto Insurance Industry [Podcast]

Event Details

Start: April 28, 2020 @ 8:00PM EDT End: @ Location: Online Event

Social distancing guidelines across the country have led to fewer cars on the road and, as a result, a decline in auto accidents. In California alone, accidents have decreased by about half since instituting shelter-in-place restrictions, according to a UC Davis study. To learn more about the changes on the road and in the auto insurance industry overall, we sat down with Mitchell Executive Vice President and General Manager Debbie Day and Senior Vice President of Regulatory Compliance Management Michele Hibbert-Iacobacci. Listen to the podcast to hear more.

Debbie Day, Executive Vice President and General Manager, Auto Physical Damage

As Debbie Day points out, COVID-19 is prompting the industry to think and act differently. Leveraging technology, carriers and repairers are transitioning to new workflows that better support their customers and protect their employees. With virtual claims handling, for example, companies can limit in-person contact while still providing quality service. Day also shares her insight on how the auto physical damage market can adapt to what will be a “new normal.” Her recommendations include focusing on partnerships, using technology to accelerate support for a virtual world and taking the time to reimagine both ourselves and our role in the industry. “I believe we’re going to continue down this road of innovation and come out further ahead than if we hadn’t been impacted by COVID-19,” Day said. “Collectively we’ll find new and better ways of doing business and meeting consumer needs. I believe that we’re going to continue on with proper and safe repair of vehicles. It’s a matter of when.” https://soundcloud.com/user-175242560/covid-19-implications-for-the-auto-physical-damage-industry

Michele Hibbert-Iacobacci, Senior Vice President, Regulatory Compliance Management, Casualty Solutions

Michele Hibbert-Iacobacci explains that the COVID-19 pandemic has led to not only fewer cars on the road and a reduction in car accidents, but it has also led many healthcare providers to reschedule or delay treatments for claimants. Soft tissue injuries, such as whiplash, sprains and strains, make up the majority of auto casualty claims, she said, and typically call for hands-on care from providers. Delays in treatment for auto accident-related injuries could lead to potential issues for claimants down the line. Overall, Hibbert-Iacobacci believes this pandemic will leave lasting effects on the industry. “Normally, when we see crashes go up, lots of people are employed,” she said. “When unemployment happens, we see less. There’s a correlation there. Overall, we believe the auto industry will certainly rebound and it will be very similar to the way it was prior, but it’s going to [take] the next six to eight months to get back to the level of frequency and duration the way it was before. “We also believe that many employers may like having their employees work at home. There may still be this aspect of folks not being back on the road as much as they were before. That remains to be seen.” Learn More

More stories

Workers' Comp Article

Ask The Pharmacist: FDA Approval of Non-Opioid Medication for Acute Pain

April 1, 2025

The U.S. Food and Drug Administration (FDA) recently approved Journavx (suzetrigine), a novel non-opioid medication developed by Vertex Pharmaceuticals for the treatment of moderate to severe acute pain in adults. This approval, announced on January 30, 2025, marks a significant milestone in pain management, introducing the first new class of oral medication for acute pain in over two decades.

Risk & Insurance In the News

The AI Balancing Act: Navigating Innovation in Workers’ Compensation

March 26, 2025

Industry expert Michael Cwynar of Enlyte discusses how to strike the right balance between AI innovation and professional expertise in today’s rapidly evolving tech landscape.

Workers' Comp Article

10 Ways Field Case Management Can Make a Difference

March 25, 2025

Enlyte's field case management provides empathetic, innovative support for injured employees, guiding recovery with tailored solutions. Discover how our comprehensive approach can enhance your workers' compensation outcomes.

Workers' Comp Article

Enlyte’s Medical Price Index – Q1 2025 Report

March 25, 2025

As reported by the Bureau of Labor and Statistics (BLS) in January 2025 for December 2024, the United States consumer price index increased to 2.9% over the preceding 12 months which is 0.5% higher than reported in October 2024.

Workers' Comp Article

Empowering Injured Employees to Return to Work through Vocational Case Management

March 25, 2025

Explore vocational case management's role in workers' compensation. Learn about services, qualifications, benefits, and when to refer for vocational rehabilitation to improve return-to-work outcomes and reduce claim costs.

Workers' Comp White Paper

A Comprehensive Guide to Outcomes-Based Networks

March 24, 2025

Download the Comprehensive Guide to Outcomes-Based Networks and discover how strategic channeling, advanced analytics, and evidence-based care are reshaping the future of workers’ compensation.

  • Load More
Enlyte Logo
  • Media
  • Careers
  • Contact Us

Mitchell

Genex

Coventry

Apricus

twitter X social media icon twitter LinkedIn social media icon twitter YouTube social media icon

©2026 Enlyte Group, LLC. All rights reserved.

Terms of Use

Privacy Practices

Minnesota Rehabilitation Services

Verisys

California Privacy Rights